| Infectious Diseases Society of America Guidelines on the Treatment and Management of Patients with COVID-19 A Bhimraj, RL Morgan, AH Shumaker, V Lavergne, L Baden, VC Cheng, ... Clin Infect Dis, ciaa478, 2020 | 1278 | 2020 |
| Nirsevimab for prevention of RSV in healthy late-preterm and term infants LL Hammitt, R Dagan, Y Yuan, M Baca Cots, M Bosheva, SA Madhi, ... New England Journal of Medicine 386 (9), 837-846, 2022 | 515 | 2022 |
| Age-related differences in nasopharyngeal SARS-CoV-2 levels in mild-moderate COVID-19 T Heald-Sargent, WJ Muller, X Zheng, J Rippe, AB Patel, LK Kociolek JAMA Pediatrics, 2020 | 437* | 2020 |
| Clinical and in vitro evaluation of cidofovir for treatment of adenovirus infection in pediatric hematopoietic stem cell transplant recipients WJ Muller, MJ Levin, YK Shin, C Robinson, R Quinones, J Malcolm, ... Clinical infectious diseases 41 (12), 1812-1816, 2005 | 107 | 2005 |
| Efficacy of nirsevimab against respiratory syncytial virus lower respiratory tract infections in preterm and term infants, and pharmacokinetic extrapolation to infants with … EAF Simões, SA Madhi, WJ Muller, V Atanasova, M Bosheva, F Cabañas, ... The Lancet Child & Adolescent Health 7 (3), 180-189, 2023 | 104 | 2023 |
| Nirsevimab for prevention of RSV in term and late-preterm infants WJ Muller, SA Madhi, B Seoane Nuñez, M Baca Cots, M Bosheva, ... New England Journal of Medicine 388 (16), 1533-1534, 2023 | 99 | 2023 |
| Non-invasive diagnosis of infection using plasma next-generation sequencing: A single center experience CS Armstrong AE, Rossoff J, Hollemon D, Hong DK, Muller WJ Open Forum Infectious Diseases, 2019 | 98 | 2019 |
| Early viral suppression improves neurocognitive outcomes in HIV-infected children CS Crowell, Y Huo, K Tassiopoulos, KM Malee, R Yogev, R Hazra, ... AIDS 29, 295-304, 2015 | 98 | 2015 |
| Comparison of upper respiratory viral load distributions in asymptomatic and symptomatic children diagnosed with SARS-CoV-2 infection in pediatric hospital testing programs LK Kociolek, WJ Muller, R Yee, J Dien Bard, CA Brown, PA Revell, ... Journal of clinical microbiology 59 (1), 10.1128/jcm. 02593-20, 2020 | 91 | 2020 |
| Cell-free DNA next-generation sequencing successfully detects infectious pathogens in pediatric oncology and hematopoietic stem cell transplant patients at risk for invasive … CS Armstrong AE, Rossoff J, Hollemon D, Hong DK, Muller WJ Pediatr Blood Cancer 66 (7), e27734, 2019 | 86 | 2019 |
| Neurologic disease in HIV‐infected children and the impact of combination antiretroviral therapy CS Crowell, KM Malee, R Yogev, WJ Muller Reviews in medical virology 24 (5), 316-331, 2014 | 80 | 2014 |
| Prevalence and Risk Factors of Neurologic Manifestations in Hospitalized Children Diagnosed with Acute SARS-CoV-2 or MIS-C EL Fink, CL Robertson, MS Wainwright, JD Roa, ME Lovett, C Stulce, ... Pediatric neurology 128, 33-44, 2022 | 79 | 2022 |
| SARS-CoV-2 infection in infants less than 90 days old LB Mithal, KZ Machut, WJ Muller, LK Kociolek The Journal of pediatrics 224, 150-152, 2020 | 78 | 2020 |
| Evaluation of mRNA-1273 Vaccine in Children 6 Months to 5 Years of Age EJ Anderson, CB Creech, V Berthaud, A Piramzadian, KA Johnson, ... New England Journal of Medicine 387 (18), 1673-1687, 2022 | 73 | 2022 |
| Airway deposition of hygroscopic heterodispersed aerosols: results of a computer calculation DD Persons, GD Hess, WJ Muller, PW Scherer Journal of Applied Physiology 63 (3), 1195-1204, 1987 | 65 | 1987 |
| Immunobiology of herpes simplex virus and cytomegalovirus infections of the fetus and newborn WJ Muller, CA Jones, DM Koelle Current immunology reviews 6 (1), 38-55, 2010 | 59 | 2010 |
| A model of cigarette smoke particle deposition WJ Muller, GD Hess, PW Scherer AIHA Journal 51 (5), 245-56, 1990 | 56* | 1990 |
| Infectious diseases Society of America guidelines on the treatment and management of patients with COVID-19. Infectious diseases Society of America 2021; Version 4.2. 0 A Bhimraj, RL Morgan, AH Shumaker, V Lavergne, L Baden, VC Cheng, ... Version 10 (0), 2021 | 52 | 2021 |
| The immunologic basis for severe neonatal herpes disease and potential strategies for therapeutic intervention WJ Muller Clinical and Developmental Immunology 2013, 2013 | 49 | 2013 |
| Pathways for uptake of fluorescently labeled liposomes by alveolar type II cells in culture. WJ Muller, K Zen, AB Fisher, H Shuman The American journal of physiology 269, L11-9, 1995 | 49 | 1995 |
David M. KoelleUniversity of Washington Depts. of Medicine, Laboratory Medicine, and Global HealthVerified email at u.washington.edu
